Beneficial effects of anisodamine in shock involved cholinergic anti-inflammatory pathway

Frontiers in Pharmacology

Volumn MAY, Issue , 2011, Pages

  Zhao, Ting ^a   Li, Dong Jie ^a   Liu, Chong ^a   Su, Ding Feng ^a   Shen, Fu Ming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

7nachr; Acetylcholine; Anisodamine; inflammation; Shock

Indexed keywords

ACETYLCHOLINE; ANISODAMINE; ATROPINE; BUNGAROTOXIN RECEPTOR; DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; METHYLLYCACONITINE; NORADRENALIN; PHENOXYBENZAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; ENDOTOXEMIA; EPIDEMIC MENINGITIS; HUMAN; HYPOVOLEMIA; IMMUNOMODULATION; MICROCIRCULATION; NONHUMAN; RECEPTOR BLOCKING; SEPTIC SHOCK; SHIGELLOSIS; SHOCK; TRAUMATIC SHOCK; TREATMENT OUTCOME; VAGUS REFLEX;

EID: 84866113810     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2011.00023     Document Type: Article

References (19)

1. Anonymous. (1975). Anisodamine in treatment of some diseases with manifestations of acute microcirculatory insufficiency. Chin. Med. J. 1, 127-132.
2. Baldwin, A. S. Jr. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
3. Hock, C. E., Su, J. Y., and Lefer, A. M. (1983). Salutary effects of anisodamine in murine traumatic shock. Circ. Shock 11, 211-216.
4. Huang, Y. S., Li, A., and Yang, Z. C. (1990). Roles of thromboxane and its inhibitor anisodamine in burn shock. Burns 16, 249-253.
5. Li, D. J., Evans, R. G., Yang, Z. W., Song, S. W., Wang, P., Ma, X. J., Liu, C., Xi, T., Su, D. F., and Shen, F. M. (2011). Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension. Hypertension 57, 298-307.
6. Libert, C. (2003). Inflammation: a nervous connection. Nature 421, 328-329.
7. Liu, C., Shen, F. M., Le, Y. Y., Kong, Y., Liu, X., Cai, G. J., Chen, A. F., and Su, D. F. (2009). Anti-shock effect of anisodamine involves a novel pathway for activating a7 nicotinic acetylcholine receptor. Crit. Care Med. 37, 634-641.
8. Poupko, J. M., Baskin, S. I., and Moore, E. (2007). The pharmacological properties of anisodamine. J. Appl. Toxicol. 27, 116-121.
9. Ruan, Q. R., Zhang, W. J., Hufnagl, P., Kaun, C., Binder, B. R., and Wojta, J. (2001). Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kB pathway. J. Vasc. Res. 38, 13-19.
10. Sheng, C. Y., Gao, W. Y., Guo, Z. R., and He, L. X. (1997). Anisodamine restores bowel circulation in burn shock. Burns 23, 142-146.
11. Su, J. Y., Hock, C. E., and Lefer, A. M. (1984). Beneficial effect of anisodamine in hemorrhagic shock. Naunyn Schmiedebergs Arch. Pharmacol. 325, 360-365.
12. Su, J. Y., Wu, L., and Tang, C. (1983). Experimental study in rabbits of the antishock effect of anisodamine (654-2), and its mechanism of action. Resuscitation 10, 173-184.
13. Tak, P. P., and Firestein, G. S. (2001). NF-kB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11.
14. van Westerloo, D. J. (2009). A new approach to step on the vagal anti-inflammatory gas pedal. Crit. Care Med. 37, 778-779.
15. Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Yang, H., Ulloa, L., Al-Abed, Y., Czura, C. J., and Tracey, K. J. (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388.
16. Wang, S. T., and Kuo, N. L. (1978). Experience in emergency treatment of shock due to infection. Chin. Med. J. 6, 497-500.
17. Xiu, R. J. (1980). Studies on microcirculation in the Institute of Basic Medical Sciences, Chinese Academy Medical Science. Microvasc. Res. 20, 371-373.
18. Xiu, R. J., Hammerschmidt, D. E., Coppo, P. A., and Jacob, H. S. (1982). Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation: a possible mechanism for its efficacy in bacteremic shock. JAMA 247, 1458-1460.
19. Yang, B. F., and Su, D. F. (2008). "Antagonists of muscarinic receptors," in Pharmacology, 7th Edn, C. Y. Zhang (Beijing: People's Medical Publishing House), 72-79.